Emergent BioSolutions Inc. financial data

Symbol
EBS on NYSE
Industry
Pharmaceutical Preparations
Location
300 Professional Dr, Gaithersburg, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 107 % -15.7%
Quick Ratio 52 % +10.5%
Debt-to-equity 193 % +55.2%
Return On Assets -33.4 % -55.2%
Operating Margin -40.8 % +19.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.9M shares +2.12%
Common Stock, Shares, Outstanding 52.9M shares +2.12%
Entity Public Float 381M USD -74.6%
Common Stock, Value, Issued 100K USD 0%
Weighted Average Number of Shares Outstanding, Basic 52.6M shares +3.75%
Weighted Average Number of Shares Outstanding, Diluted 52.6M shares +3.75%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.1B USD +2.79%
Research and Development Expense 92.5M USD -41.8%
Operating Income (Loss) -450M USD +16.9%
Nonoperating Income (Expense) -129M USD -7659%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -578M USD -6.43%
Income Tax Expense (Benefit) 8.9M USD -84.1%
Net Income (Loss) Attributable to Parent -587M USD +2.44%
Earnings Per Share, Basic -11.2 USD/shares +6.44%
Earnings Per Share, Diluted -11.2 USD/shares +6.44%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 69.7M USD -21.3%
Accounts Receivable, after Allowance for Credit Loss, Current 196M USD -32.3%
Inventory, Net 318M USD -10.4%
Assets, Current 655M USD -15.8%
Property, Plant and Equipment, Net 306M USD -22.6%
Operating Lease, Right-of-Use Asset 13.7M USD -12.7%
Intangible Assets, Net (Excluding Goodwill) 534M USD -9.9%
Goodwill 0 USD -100%
Other Assets, Noncurrent 18.7M USD -90.4%
Assets 1.51B USD -30.5%
Accounts Payable, Current 95.9M USD -11.5%
Employee-related Liabilities, Current 66.7M USD -4.17%
Accrued Liabilities, Current 17.2M USD -44.9%
Contract with Customer, Liability, Current 6.2M USD -56.6%
Liabilities, Current 620M USD -10.6%
Contract with Customer, Liability, Noncurrent 5.9M USD -88.8%
Deferred Income Tax Liabilities, Net 34.8M USD -39.9%
Operating Lease, Liability, Noncurrent 11.5M USD -12.2%
Other Liabilities, Noncurrent 25.7M USD +9.83%
Liabilities 1.13B USD -7.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.5M USD -244%
Retained Earnings (Accumulated Deficit) -296M USD -202%
Stockholders' Equity Attributable to Parent 386M USD -59.7%
Liabilities and Equity 1.51B USD -30.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -62.6M USD +66%
Net Cash Provided by (Used in) Financing Activities 40.7M USD
Net Cash Provided by (Used in) Investing Activities -10.8M USD +28.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 58.5M shares +1.92%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -32.7M USD +84.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 71M USD -19.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 21.5M USD -0.46%
Deferred Tax Assets, Valuation Allowance 258M USD +296%
Deferred Tax Assets, Gross 270M USD +106%
Operating Lease, Liability 14.6M USD -12.6%
Depreciation 49M USD -32.6%
Payments to Acquire Property, Plant, and Equipment 10.8M USD -28.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -591M USD +0.62%
Lessee, Operating Lease, Liability, to be Paid 20.4M USD -13.2%
Property, Plant and Equipment, Gross 707M USD -10.2%
Operating Lease, Liability, Current 3.1M USD -13.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.7M USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.3M USD -33.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +22.2%
Deferred Income Tax Expense (Benefit) 1.9M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.1M USD +6.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.9M USD +7.41%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 6.6M USD -2.94%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.3M USD 0%
Additional Paid in Capital 915M USD +2.18%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 65M USD 0%
Depreciation, Depletion and Amortization 27.9M USD -19.4%
Deferred Tax Assets, Net of Valuation Allowance 11.7M USD -82.2%
Share-based Payment Arrangement, Expense 19.4M USD -48.9%
Interest Expense 94.3M USD +101%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%